National Scientific Committee

DR. SANYOG JAIN is currently working as Professor and Head at Department of Pharmaceutics of National Institute of Pharmaceutical Education and Research (NIPER), Mohali (Punjab), India. Previously he worked as Scientist at Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India. His key research interest includes exploring different types of nano drug delivery systems for various biomedical applications including targeted anticancer drug delivery, oral delivery of vaccines, peptides and other small molecules, co-delivery of anticancer drugs, topical and transdermal drug delivery and gene delivery. He has patented several nanotechnology based drug delivery platforms and licensed Tamoxifen-SEDDS Technology for improved breast cancer therapy to industry for commercialization. Dr. Jain is inventor of 14 granted patents. He has authored 2 books, 11 book chapters and published over 250 research papers in high impact international journals (h-index 67) with more than 14500 citations.

Dr. Jain has won several prestigious awards including AAPS Fellow- 2022, AAiPS Distinguished Young Educator and Research Scholarship Award, ABAP Gold medal for Advanced Research in Nano science and Technology, Shivnath Rai Kohli Memorial Mid Career Best Scientist Award, Pharm Innova Award for Best Research Guide (three times in 2014-15, 2016-17 and 2017-18), Bharat Jyoti (The Glory of India) Award, Rising Suns in Asia Award, Alkyl Amine Young Scientist Award, INSA Medal for young scientists, OPPI Young Scientist Award and Punjab State Young Scientist Award for his outstanding research in the field of nanomedicine and novel drug delivery systems. He also Secured rank in list of World’s top 2% Scientists (in the field of Pharmacy and Pharmacology) published by Stanford University, and Elsevier in 2020, 2021, 2022, 2023 and 2024.

Most recently, he has been honored with APTI Research Excellence Award in Pharmaceutics and Drug Delivery. Dr. Jain is serving as expert committee member of Radiopharmaceutical Committee of Department of Atomic Energy (DAE), Govt of India. He is Editor of AAPS PharmSciTech since 2014 and also Editorial Advisory Board Member of Molecular Pharmaceutics and Drug Delivery and Translational Research

Dr Arvind Kumar Bansal is currently Professor, department of Pharmaceutics at National Institute of Pharmaceutical Education and Research (NIPER) – SAS Nagar, Punjab, India. He earned his M Pharm (Pharmaceutics) (1988) and Ph.D. (1993) from University of Delhi, India.

Prof Bansal worked as Senior Scientist and Group Leader in JK Pharmaceuticals and Ranbaxy Research Laboratories, for 8 years. Therein he conceptualised, evolved formulation strategies, developed and transferred the technology to production shop floor, for NCEs and generic drug products.

Prof Bansal joined NIPER in 2000 and has developed expertise in areas of pre-formulation and formulation development encompassing characterization and stabilization of the amorphous form, polymorphism, pseudo-polymorphism, particle engineering, screening salt forms, improvement of oral bioavailability and lyophilization. His research group works with the mission statement – ‘developing science based industrially viable pharmaceutical technologies’ and works closely with pharmaceutical industry to create opportunities for commercial exploitation of the products.

Dr Bansal was conferred prestigious Fellow of American Association of Pharmaceutical Sciences in 2016. He is the first Indian working India being awarded this Fellow status. He has won prestigious awards like AAiPS Distinguished Educator and Researcher Award, Innocentive Award and OPPI Award.

Prof Bansal’s research group has completed nearly 700 industry sponsored projects, granted 08 patents, filed 27 patents, and published ~225 research articles and 26 review articles. He is an editorial board member of Journal of Excipients and Food Chemicals and Pharmaceutics. He is also an Advisor to the editorial board of Journal of Pharmaceutical Sciences and on Editorial Board of Molecular Pharmaceutics. His lab has out-licensed a platform technology on “Nano crystalline solid dispersions – NanoCrySP.

Vijay is an accomplished Quality, Regulatory & Analytical professional with about 40 years of rich experience of working for highly reputed Indian & Multinational Pharma firms like Unichem, Ranbaxy, Sun Pharma , Lupin, IPCA, German Remedies  in  Sr positions like EVP, Director & GM- Quality & Regulatory. He has led from front for several successful regulatory inspections including US FDA, MHRA, WHO, EDQM, ANVISA, TGA both for Drug Products & API’s.

Since 2013, he is running his own Pharma Consultancy called TRAC offering specialized services globally, for cGMP Training, Regulatory Filings, Auditing & Compliance. His current clients include reputed pharma companies based in India, China, Bangladesh, Turkey, US, Europe, Malaysia etc..  He is a frequent international trainer on several cGMP related topics.

He is the founder President of ‘Society for Pharmaceutical Dissolution Science’. He is currently working on the board of Directors of ISPE-India. IDMA has conferred upon him an ‘Outstanding Analyst Award 2011’ for his contribution towards pharmaceutical analysis. He has also published articles on cGMP related topics like CAPA, OOS, QbD & cGMP in reputed journals/books. He is M.Sc. by Research in Organoanalytical Chemistry from Mumbai University. He has a good Microbiological background too

Dean Research and Innovation, Professor in Pharmacy and former Head, Department of Pharmaceutical Sciences and Technology at the Institute of Chemical Technology, Mumbai, India. She is also a member of the Board of Governors and Head of the Incubator at the Institute of Chemical Technology.

She has many granted patents, has licensed technologies to industry and products commercialized in India and Europe.  She is author of two books on Targetted Drug Delivery, published by Springer. She was actively associated with Controlled Release Society Inc., USA as Board Member, Member on the Board of Scientific Advisors, Chair of the Young Scientist Mentor Protégé Committee and Chair of the Outstanding Paper Award Committee of the Journal Drug Development and Translational Research. She is a Member on the Editorial board of the Asian Journal of Pharmaceutical Sciences and the European Journal of Drug Metabolism and Pharmacokinetics.

Prof. Devarajan is a nominated Fellow of the Maharashtra Academy of Sciences, and Life Fellow of the Indian Chemical Society. She is  a recipient of several awards and recognitions for Research and Innovation,  including the American Association of Indian Pharmaceutical Scientists Distinguished Educator and Researcher Award, the VASVIK award for Industrial Research, the APTI Award for Research in Pharmaceutical Sciences,  OPPI Scientist Award the Bengaluru Nano Innovation Award and   the Outstanding Woman Scientist Award of ICAR, Government of India.

Dr. Mangal Nagarsenkar is Professor Emeritus and former Head, Department of Pharmaceutics, Bombay College of Pharmacy, Mumbai, India. She is also associated as Research Adviser at Vivekanand Education Society’s college of pharmacy.

Prof. Nagarsenkar has more than 3 decades of research experience in the field of novel drug delivery systems. She has successfully guided many M.Pharm and Ph.D students. She has authored 118 research articles in national and international journals, 9 review articles, 7 book chapters and 2 books. She is a member of the editorial advisory board of IJPS, editorial advisory board of Drug Delivery Letters, Bentham Publication and has served as a reviewer for various national and international journals. Her research collaborations include University of Jena, Germany, University of Helsinki, Finland, G S medical college, Mumbai, ACTREC, Navi Mumbai, IICT, Hyderabad and CDRI, Lucknow. She has 2 US patents, 5 Indian patents and 3 trademarks to her credit.

She has been a recipient of awards and recognition including Prof. (Mrs.) M. R. Baichwal Visiting fellow in Pharmaceutical Sciences and Technology in UICT (2005-2006), Amrut Mody Research Fund, Distinguished Researcher National Award (2012), Association of Pharmaceutical Teachers of India (APTI) Dr. (Mrs.) Manjushree Pal Best Researcher National Award (2013), IPA MSB Student forum- Life Time Achievement Award (2021), APTI- MSB and Karyakaushalam, Mumbai -Certificate of honour for excellence in  education(2024)  .

Prof. Nagarsenker’s research interests  include lipid nanocarriers for improved and targeted drug delivery,  Solubilisation and dissolution  and design  of novel ligands for targeted drug delivery.

Email: mangal.nagarsenker@gmail.com

Dr. Abha Doshi is a distinguished academic and professional in the field of Pharmaceutical Sciences, currently serving as the Principal and Professor at the MET Institute of Pharmacy (Degree), Bandra Reclamation, Mumbai. With a career spanning over 28 years, Dr. Doshi has made significant contributions to both the education and pharmaceutical industries.

Educational Background:

• B. Pharm. (1984) and M. Pharm. (1986) from Dr. H. S. Gour University, Sagar, Madhya Pradesh.
• Ph.D. (1997) in Pharmaceutical Technology from C. U. Shah College of Pharmacy, SNDT Women’s University, Mumbai.

Professional Experience:

• Dr. Doshi started her career in the pharmaceutical industry by working for Ranbaxy Laboratories Ltd., Dewas (M.P.) in Tablet Production for three years.
• She then transitioned to academia, joining MET Institute of Pharmacy (Degree) in 1996 as a lecturer. Over time, she rose to the position of Professor and Principal, where she has been guiding students and leading the institution for over two decades.

Research and Contributions:

• Dr. Doshi has been a prolific researcher, contributing to the field of pharmaceutical sciences, particularly in areas like gastro-retentive drug delivery, nanoparticles, and mucoadhesive drug delivery.
• She has presented 21 research papers at national and international seminars and conferences.
• Her scholarly work includes 23 publications in various national and international journals.
• Dr. Doshi has also made significant strides in intellectual property, holding a patent for buccal patches for aphthous ulcers and having two additional patents pending.

Awards and Recognition:

• In recognition of her exceptional work, Dr. Doshi has received numerous awards, including:
  • M. L. Khorana Award (2003) for the best paper published in the Indian Journal of Pharmaceutical Sciences.
  • MET Pragyawant and MET Gaurav Awards (2019).
  • Iconic Principal Award (2021) by ASIA-GCC.
  • Best Service Award (2023) by INSO.

Leadership Roles:

• Dr. Doshi is also deeply involved in professional organizations. She is the founder trustee and executive member of the Society of Pharmaceutical Dissolution Sciences, contributing to the growth and development of the pharmaceutical industry.

Her vast experience and accomplishments make Dr. Abha Doshi a highly respected figure in both academia and the pharmaceutical industry.

Email: abhad_iop@met.edu

Dr (Mrs) Mala D.Menon is currently Adjunct Professor of Pharmaceutics, Bombay College of Pharmacy (BCP) , Mumbai. She joined BCP way back in 1986 after working with Pharma Industry for 2 years.

Her research areas include Novel Drug Delivery systems, mainly Nasal & Pulmonary systems and Ocular systems; Probiotics, Novel vaccine delivery approaches, Novel Veterinary Drug Delivery Systems, Enzyme delivery systems, Dissolution rate test evaluations.

She had handled many research projects from Government agencies – from AICTE, UGC, BRNS, Mumbai University; and Industry sponsored projects from Yash Pharma, US Vitamins, Mother Dairy, Hansen Probiotics, Glenmark, Famy Health Care, Abbott India, Getz Pharma, Pfizer, Valois Pharma (now APTAR Pharma)-France, Lupin (USA), Saife Vetmed, Gattafosse, Lubrizol and ACG.

She is a recipient of several awards, including – Dr. P. D. Patil Best Pharmaceutical Scientist Award (APTI- Maharashtra State Branch, March 2016); Best Professor of Pharmaceutics (National Education Awards -8th edition, ABP News Channel, July 2017); Promising Innovation in Solid Dosage Form (IPA-ACG Scitech, Dec. 2018); Best Professor in Pharmaceutics (26 th Business School Affaire and Dewang Mehta National Education Award, Nov. 2018); Distinguished Professor Award at the Stakeholder Workshop (SPAICS)- sponsored by National Science & Technology Management Information System (NSTMIS) a Divn of DST, held at Smriti College of Pharmacy at Indore on 28th Sept, 2019; Lifetime Achievement Award (Indian Pharmaceutical Association, Maharashtra State Branch Students’ Forum (IPA-MSB-SF) on 25th Sept, 2021.

Email: maladmbcp@gmail.com

• Prof Krishnapriya Mohanraj is Principal in Charge, Professor of Pharmaceutical Analysis and Chairperson-Industrial Collaborations and Resource Mobilization at Bombay College of Pharmacy (BCP), a premier Pharmacy institute. She is former Coordinator- AICTE Quality Improvement Program and President, Institute Innovation Council at BCP. She is Global Chair- Dissolution Research Presentations International, a competition conducted by SPDS.
• Passionate educator, motivating and training students, analysts, chemists and faculty in the nuances of pharmaceutical analysis and medicinal chemistry; and a researcher developing novel and cost-effective techniques useful for the industry, with more than 30 years’ experience.
• M Pharm and PhD (Tech) from Institute of Chemical Technology (formerly UDCT) Mumbai,
• Experience of more than 30 years handling several academic and administrative positions
• Research funding of more than INR 8 crores from various agencies like Department of Science and Technology, Department of Biotechnology, AYUSH, All India Council of Technical Education, University Grants Commission, University of Mumbai, Amrut Mody Research Fund and from several industries based in India and abroad including sanction of Rs 5.87 crores for co-establishment of National Facility of Research and Training in Integrated Analytical Strategies for Discovery, Development and Testing of Drugs, Pharmaceuticals and Nutraceuticals at Bombay College of Pharmacy under the Drugs and Pharmaceuticals Research Promotion Scheme of the Department of Science and Technology with high end instruments like LC-MS/MS, ICP-MS and HPTLC-MS.
• One patent and one Technology Transfer, many publications and presentations, 6 of which have won awards.
• Consultancy: worth more than INR 2 crores with organizations like Shogun Organics, Aarti Industries, Sanofi Aventis, Analytical Solutions, Glaxo Smith Kline, Ambernath Organics, Sandu Pharma, Nerlikar Hospital, SG Pharma, Loba Chemie, Nature Pure, Hi Media, ACG Worldwide, Dharmayug Biosciences, Alpha MD, Micro-Tracers Inc (USA), Ajanta Pharma, Macleods Pharma, Glenmark, Anshul Life Sciences, GS Medical College and KEM Hospital, Abbott, Nature Pure, Teledyne Hanson (USA), Aristo Pharma and Rubicon Research.
• Expertise in LC-MS-MS, HPLC, chiral HPLC, HPTLC, HPTLC-MS, and ICP-MS analysis, Quantitative LC-MS/MS Analysis of Nitrosamine Drug Related Substance Impurities (NDSRIs), Bioanalytical Method development and validation; Therapeutic Drug Monitoring and pharmacokinetic analysis, Herbal Analysis and Nutraceutical Analysis.
• Member, CII Education Council Task Force for Industry Academia Partnership and Member, CII Education Council Task Force Entrepreneurship & Start-ups Ecosystem (2022-23) and Member of PHD Chamber of Commerce and Industry – National Education Committee, 2023.
• Recipient of the UKIERI Indo UK Staff Exchange Program 2011-12 Award by the British Council, Fabulous Global Healthcare Leader Award, Most Iconic Healthcare Leaders (Global) Award.

Email: krishnapriyamohanraj@gmail.com

Kalyan is a doctorate in Chemistry from University of Madras with 25+ years of experience in Analytical Research.  He is currently working with Dr. Reddy’s as Senior Director– AR&D heading the AR&D of Oral Solid Dosages and Integrated APIs. Kalyan is an expert in Method design, structure elucidation by NMR & Mass spectroscopy and Solid state characterization. He has extensive experience in handling Complex Generic APIs and dosage forms for establishing sameness using advance analytical techniques. He has got publications in national and international journals on separation and characterization of impurities in drugs and has delivered talks in a variety of topics on Analytical Development in various conferences.

Dr. BM Rao possess a Ph.D. degree in Chemistry and has about 27 years of work experience in pharmaceutical Analytical R&D and Quality Control functions in reputed organizations includes Janssen (pharmaceutical companies of Johnson & Johnson, Novartis, Zydus Cadila, Nicholas Piramal, and Dr. Reddy’s. He has a sound practical knowledge and thorough understanding of “Data Integrity”, its importance in cGMP Analytical laboratories. He has exposure to various regulatory audits includes USFDA, EMEA, TGA, Health Canada etc. and also worked with reputed International consultants in QC remediation.   He has about 75 scientific publications in reputed national and international journals and successfully guided seven part-time Ph.D. candidates.

During his professional career he has been recognized for his contributions at work and won awards including Chairman’s Excellence Award from Dr. Reddy’s Laboratories (Feb, 2018), “Standards of Leadership” from J&J at Janssen, Mumbai site (year 2010) and Best New Leader Award at SAI Life Sciences Limited (year 2013). He has extensively travelled to USA, Mexico, Europe, Germany, Belgium, Singapore, Brazil, and Malaysia and interacted with several big and emerging biotech pharmaceutical analytical & quality experts.

At present, Dr. BM Rao is working as Vice President and Head of Analytical Science & Technology (ASAT) & Corporate Quality control at Dr. Reddy’s Laboratories providing technical leadership to the Analytical method validations/transfers and Quality Control labs of APIs and Formulations.

Dr. Santhanakrishnan Srinivasan is an accomplished research professional in the field of Pharmaceutics and drug development. He brings with himself wealth of knowledge and expertise in the field of sterile drug product development and also in the process development and in-vitro dissolution method development of modified release, delayed release oral formulations and long acting parenteral and ophthalmic formulations.

Dr. Srinivasan holds a Ph.D in Chemical Engineering from University of Missouri – Rolla. In his decade long industrial career, he has held R&D leadership position at Dr. Reddy’s Laboratories and Amneal Pharmaceuticals.

Email: santhanas@amneal.com